multiple myeloma multiple myeloma post autologous stem cell transplantation ASCT maintenance
Conditions
Interventions
Multiple myeloma patients after autologous stem cell transplantation
Other
maintenance therapy
Sponsors
Mahidol University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Aged 18 years and above 2. Multiple myeloma patients receiving autologous stem cell transplantation at Siriraj Hospital
Exclusion criteria
Exclusion criteria: 1.insufficient data needed for analysis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression free survival at progression of disease or death the time from maintenance to progression or death | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival at death the time from maintenance to death,Incidence of secondary primary malignancy within 2 years number of patient who hassecondary primary malignancy after maintenance therapy,Adverse events within 2 years number of adverse event,proportion of patients who receive maintenance therapy and type of drug after ASCT number of patients who receive maintenance therapy ,Response rate within 2 years evaluate from labouratory and imaging result | — |
Countries
Thailand
Contacts
Public ContactChutima Kunacheewa
Faculty of Medicine Siriraj Hospital
Outcome results
None listed